Skip To Main Content
Panudda Srichomkwun on Muck Rack

Panudda Srichomkwun

As seen in: Nature, Journal of Medical Case Reports
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Panudda

Contact Panudda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mobile application-based lifestyle intervention versus standard care for diabetes prevention in healthcare personnel with prediabetes: a randomized controlled trial

|
By Natnicha Houngngam, Prangareeya Santisitthanon, Nitchakarn Laichuthai, Panudda Srichomkwun, Natthaphon Wonghakaeo, Jutipond Jitchana, Sitamanats Suwanachaiy, Chalisa Rattanabumrung
| Nature Verified
Abstract Prediabetes increases the risk of progression to type 2 diabetes (T2DM). This study evaluated the efficacy of a mobile application-based lifestyle intervention compared with standard care in individuals with prediabetes. In this open-label randomized controlled trial, healthcare personnel with prediabetes at a tertiary-care hospital in Bangkok, Thailand, were randomly assigned to either a mobile application–based intervention or standard care.
Open in Who Shared Issue with article?

Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report

|
By Thachanun Porntharukchareon, Borwonkhun Tontivuthikul, Nattaya Sintawichai, Panudda Srichomkwun
| Journal of Medical Case Reports Verified
Abstract Background Several human monoclonal antibodies directed against immune checkpoints, including T lymphocyte antigen 4 and programmed cell death protein 1, have been implemented for cancer treatment in order to promote effector T cell response to tumors. Despite the antitumor activity of these agents, a significant number of patients demonstrated immune-related adverse events that affected the functions of multiple organs, including the endocrine system.
Open in Who Shared Issue with article?
See all 2 articles